A "Chemical ChatGPT" for New Medications

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of ChatGPT for molecules. Following a training phase, the AI was able to exactly reproduce the chemical structures of compounds with known dual-target activity that may be particularly effective medications. The study has now been published in Cell Reports Physical Science.

Anyone who wants to delight their granny with a poem on her 90th birthday doesn’t need to be a poet nowadays: A short prompt in ChatGPT is all it takes, and within a few seconds the AI spits out a long list of words that rhyme with the birthday girl’s name. It can even produce a sonnet to go with it if you like.

Researchers at the University of Bonn have implemented a similar model in their study – known as a chemical language model. This does not, however, produce rhymes. Instead, the AI displays the structural formulas of chemical compounds that may have a particularly desirable property: They are able to bind to two different target proteins. In the organism, this means, for example, they can inhibit two enzymes at once.

"2In pharmaceutical research, these types of active compounds are highly desirable due to their polypharmacology," explains Prof. Dr. Jürgen Bajorath. The computational chemistry expert heads the AI in Life Sciences area at the Lamarr Institute for Machine Learning and Artificial Intelligence and the Life Science Informatics program at b-it (Bonn-Aachen International Center for Information Technology) at Uni Bonn. "Because compounds with desirable multi-target activity influence several intracellular processes and signaling pathways at the same time, they are often particularly effective - such as in the fight against cancer." In principle, this effect can also be achieved by co-administration of different drugs. However, there is a risk of unwanted drug-drug interactions and different compounds are also often broken down at different rates in the body, making it difficult to administer them together.

Finding a molecule that specifically influences the effect of a single target protein is no easy task. Designing compounds that have a predefined double effect is even more complicated. Chemical language models may help here in the future. ChatGPT is trained with billions of pages of written text and learns to formulate sentences itself. Chemical language models work in a similar way, but only have comparably very small amounts of data available for learning. However, in principle, they are also fed with texts, such as what are known as SMILES strings, which show organic molecules and their structure as a sequence of letters and symbols. "We have now trained our chemical language model with pairs of strings," says Sanjana Srinivasan from Bajorath’s research group. "One of the strings described a molecule that we know only acts against one target protein. The other represented a compound that, in addition to this protein, also influences a second target protein."

The model was fed with more than 70,000 of these pairs. This allowed it to acquire an implicit knowledge of how the normal active compounds differed from those with the double effect. "When we then fed it with a compound against a target protein, it suggested molecules on this basis that would act not only against this protein but also against another," explains Bajorath.

The training compounds with the double effect often target proteins that are similar and thus perform a similar function in the body. In pharmaceutical research, however, people are also looking for active ingredients that influence completely different classes of enzymes or receptors. To prepare the AI for this task, fine-tuning took place after the general learning phase. The researchers used several dozen special training pairs to teach the algorithm which different classes of proteins the suggested compounds should target. This is a bit like instructing ChatGPT not to create a sonnet this time, but instead a limerick.

After the fine-tuning, the model actually spat out molecules that have already been shown to act against the desired combinations of target proteins. "This shows that the process works," says Bajorath. In his opinion, however, the strength of the approach is not that new compounds exceeding the effect of available pharmaceuticals can immediately be found. "It is more interesting, from my point of view, that the AI often suggests chemical structures that most chemists would not even think of right away," he explains. "To a certain extent, it triggers ‘out of the box’ ideas and comes up with original solutions that can lead to new design hypotheses and approaches."

Srinivasan, Sanjana et al.
Generation of dual-target compounds using a transformer chemical language model.
Cell Reports Physical Science, 2024. doi: 10.1016/j.xcrp.2024.102255

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...